Comparing Fluorescent Starch Nanoparticles Rinse with ICDAS for Early Caries Detection in Children
Launched by CAIRO UNIVERSITY · Dec 31, 2024
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to detect early tooth decay, known as dental caries, in children aged 6 to 11 years old. Researchers want to compare the effectiveness of a special rinse made with fluorescent starch nanoparticles to a standard method called the International Caries Detection and Assessment System (ICDAS). The goal is to see which method is better at identifying early signs of tooth decay in kids.
To participate in this study, children must have at least two teeth with early signs of decay (classified as ICDAS 1 or 2) and two teeth that do not have current decay. However, children with certain dental conditions, those wearing braces, or those whose parents do not agree to participate will not be included. If eligible, participants can expect to use the rinse and undergo assessments to help researchers learn more about the best ways to detect early tooth decay in children. This trial is not yet recruiting, so there will be more updates in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children with active initial caries.
- • At least two teeth with active caries (ICDAS 1 or 2) and two teeth with inactive caries.
- Exclusion Criteria:
- • Teeth with hypoplasia, fractures, or conditions like dentinogenesis imperfecta.
- • Children with fixed orthodontic appliances.
- • Participants whose guardians refuse consent.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Giza, Egypt
Patients applied
Trial Officials
Associate Prof. Dr. Mariam Mohsen aly, Ph.D.
Study Director
Cairo University
Dr. Reem Mohamed Fouad Wahby, Ph.D.
Study Chair
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported